JPRN-UMIN000028091
Recruiting
未知
Clinical investigation for the establishment of predictive marker for therapy-related cardiovascular adverse events onset in hematologic malignancies. - Relationship between the treatment in hematological malignancies and endothelial progenitor cells (EPC)
Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine.0 sites50 target enrollmentJuly 6, 2017
Conditionshematologic malignancies
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hematologic malignancies
- Sponsor
- Department of Hematology, Nephrology, Rheumatology, Akita University Graduate School of Medicine.
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Clinical Study to evaluate the effect of an Ayurvedic Formulation in Shwasa (Respiratory disorder)Health Condition 1: J459- Other and unspecified asthmaCTRI/2021/11/038133Vinod Kumar R H
Not yet recruiting
Not Applicable
Efficacy of Neelkanthi churna in Madhumeha w.s.r to Type 2 Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/06/034030Principal
Not yet recruiting
Phase 2
Optimal dose of centchroman in management of cyclical mastalgiaHealth Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissueCTRI/2024/08/072215ttar Pradesh University of Medical Sciences
Not yet recruiting
Not Applicable
To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.Health Condition 1: J989- Respiratory disorder, unspecifiedCTRI/2021/05/033863Principal
Completed
Phase 1
An Experimental and clinical trial to study the effect of Triphala RasayanaCTRI/2020/07/026483RGGPG Ayurvedic College and Hospital Paprola28